Cancer Test Package Male
Male Cancer Screening Blood Test Package
Direct answer: This male cancer screening package is a blood test profile designed to detect tumour marker abnormalities linked to common male cancers.
The Cancer Test Package Male is a preventive tumour marker screening panel that helps identify abnormal proteins in blood associated with prostate, liver and gastrointestinal cancers. A tumour marker is a measurable substance produced by cancer cells or the body in response to cancer. This test package is offered by healthcare nt sickcare in Pune, Maharashtra, with Home Collection Facility and Direct Walk-in Facility for local patients.
This screening profile is commonly advised for men above 40 years, those with family history of malignancy or for preventive health monitoring. Unexplained weight loss can be an early symptom. Prostate cancer is a key condition assessed through this panel.
Tests Covered in Cancer Test Package Male
- CBC – complete blood count to assess overall blood cell health and detect abnormal cell patterns.
- AFP – alpha-fetoprotein tumour marker linked to liver and germ cell cancers.
- CA19.9 – carbohydrate antigen marker associated with gastrointestinal malignancies.
- CEA – carcinoembryonic antigen used for digestive tract cancer screening.
- PSA – prostate-specific antigen for prostate cancer risk evaluation.
- Free PSA – ratio marker improving prostate cancer screening accuracy.
Who should consider this test?
Direct answer: Adult men seeking preventive cancer risk screening or advised by doctors for tumour marker evaluation.
- Men above 40 years for routine cancer risk screening
- Family history of prostate or digestive cancers
- Follow-up monitoring after cancer treatment
Related Resources
Learn more about tumour marker testing from National Cancer Institute tumour marker guide.
FAQs
This test is recommended for men above 40 years, those with family history of cancer or when advised for tumour marker screening.
It helps detect elevated tumour markers linked to prostate, liver and gastrointestinal cancers for early risk identification.
Fasting is not mandatory, but your doctor may advise preparation based on medical history.
No. This is a screening test. Abnormal results need further imaging or biopsy for confirmation.
Medical Disclaimer: This cancer screening package is for health risk assessment only and does not replace clinical diagnosis. Read full policy at disclaimer policy. Product images used on this page are AI-generated with credits to Google Gemini and Shopify Magic.
Original: $2,099.00
-70%$2,099.00
$629.70Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Male Cancer Screening Blood Test Package
Direct answer: This male cancer screening package is a blood test profile designed to detect tumour marker abnormalities linked to common male cancers.
The Cancer Test Package Male is a preventive tumour marker screening panel that helps identify abnormal proteins in blood associated with prostate, liver and gastrointestinal cancers. A tumour marker is a measurable substance produced by cancer cells or the body in response to cancer. This test package is offered by healthcare nt sickcare in Pune, Maharashtra, with Home Collection Facility and Direct Walk-in Facility for local patients.
This screening profile is commonly advised for men above 40 years, those with family history of malignancy or for preventive health monitoring. Unexplained weight loss can be an early symptom. Prostate cancer is a key condition assessed through this panel.
Tests Covered in Cancer Test Package Male
- CBC – complete blood count to assess overall blood cell health and detect abnormal cell patterns.
- AFP – alpha-fetoprotein tumour marker linked to liver and germ cell cancers.
- CA19.9 – carbohydrate antigen marker associated with gastrointestinal malignancies.
- CEA – carcinoembryonic antigen used for digestive tract cancer screening.
- PSA – prostate-specific antigen for prostate cancer risk evaluation.
- Free PSA – ratio marker improving prostate cancer screening accuracy.
Who should consider this test?
Direct answer: Adult men seeking preventive cancer risk screening or advised by doctors for tumour marker evaluation.
- Men above 40 years for routine cancer risk screening
- Family history of prostate or digestive cancers
- Follow-up monitoring after cancer treatment
Related Resources
Learn more about tumour marker testing from National Cancer Institute tumour marker guide.
FAQs
This test is recommended for men above 40 years, those with family history of cancer or when advised for tumour marker screening.
It helps detect elevated tumour markers linked to prostate, liver and gastrointestinal cancers for early risk identification.
Fasting is not mandatory, but your doctor may advise preparation based on medical history.
No. This is a screening test. Abnormal results need further imaging or biopsy for confirmation.
Medical Disclaimer: This cancer screening package is for health risk assessment only and does not replace clinical diagnosis. Read full policy at disclaimer policy. Product images used on this page are AI-generated with credits to Google Gemini and Shopify Magic.
